Form D Explorer
Avertix Medical, Inc. · CIK 1564031

Report a data issueCitable research briefCompare issuerPrivate research collection

Avertix Medical, Inc.

CIK 1564031 · Corporation · Inc. DELAWARE · EATONTOWN, New Jersey · Other Health Care

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
1
Amendments
1
Activity
Mar 11, 2025
through Sep 23, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldMar 11, 2025 · D/ASep 23, 2025 · DLater minus earlier
Reported offering amount$22,650,000$5,000,000$-17,650,000
Reported amount sold$14,253,772$1,011,667$-13,242,105
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001564031-25-000001 · Later SEC source: 0002080612-25-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Sep 23, 2025

Reported offering amount
$5,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$1,011,667

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (2)